Dinoprostone and Iloprost share 5 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.135 means 14% of the combined target set is bound by both compounds. The IDF-weighted score of 0.163 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Dinoprostone and Iloprost have in common?
Dinoprostone and Iloprost share 5 molecular targets with a Jaccard similarity of 14%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Dinoprostone and Iloprost be combined?
Dinoprostone and Iloprost share 5 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Dinoprostone or Iloprost?
In the BiohacksAI corpus: Dinoprostone has 296 PubMed-indexed studies, Iloprost has 300 studies.